We will continue HSV-1 mRNA mapping studies in order to complete our description of size, location, in vitro translation products, and temporal class of the major viral mRNAs mapping in the HSV genome. The above data, as well as nucleotide sequence analysis described elsewhere, will lead us to define typical early (Beta) and late (Beta Lambda and Lambda) """"""""promoters."""""""" We will continue our analysis by examining the products of transcription of moDel HSV-1 genes. We will use in vitro systems from infected and uninfected cells. We also will introduce prototypical HSV-1 genes into cells using one of several methods recently described by others. Once these are introduced, we will be able to determine the effect of viral superinfection on the expression of classes of HSV-1 genes. We will manipulate the sequences of the promoter regions to confirm their role in the control of viral gene expression. We will investigate the biological function of specific HSV-1 genes identified above. We pose two avenues of attack: (a) collaboration with Professors G. Cohen and R. Eisenberg of the University of Pennsylvania to use their collection of poly- and monospecific antisera against viral structural proteins to investigate specific in vitro translation products; (b) collaboration with Professor J. Stevens of the University of California, Los Angeles, in his marker rescue studies to attempt to identify specific viral genes involved in different aspect of HSV pathology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA011861-16
Application #
3163561
Study Section
Experimental Virology Study Section (EVR)
Project Start
1978-05-01
Project End
1988-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
16
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Zeier, Zane; Aguilar, J Santiago; Lopez, Cecilia M et al. (2009) A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system. J Neurovirol 15:411-24
Aguilar, Jose Santiago; Held, Katherine S; Wagner, Edward K (2007) Herpes simplex virus type 1 shows multiple interactions with sulfonated compounds at binding, penetration, and cell-to-cell passage. Virus Genes 34:241-8
Aguilar, J S; Devi-Rao, G V; Rice, M K et al. (2006) Quantitative comparison of the HSV-1 and HSV-2 transcriptomes using DNA microarray analysis. Virology 348:233-41
Aguilar, J S; Ghazal, Peter; Wagner, Edward K (2005) Design of a herpes simplex virus type 2 long oligonucleotide-based microarray: global analysis of HSV-2 transcript abundance during productive infection. Methods Mol Biol 292:423-48
Karaca, Gamze; Hargett, Danna; McLean, Tim I et al. (2004) Inhibition of the stress-activated kinase, p38, does not affect the virus transcriptional program of herpes simplex virus type 1. Virology 329:142-56
O'Neil, J E; Loutsch, J M; Aguilar, J S et al. (2004) Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model. J Virol 78:5038-44
Sun, Aixu; Devi-Rao, G V; Rice, M K et al. (2004) Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo. J Virol 78:10470-8
Sun, Aixu; Devi-Rao, G V; Rice, M K et al. (2004) The TATGARAT box of the HSV-1 ICP27 gene is essential for immediate early expression but not critical for efficient replication in vitro or in vivo. Virus Genes 29:335-43
Tran, Robert K; Lieu, Pauline T; Aguilar, Santiago et al. (2002) Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice. J Virol 76:2199-205
Yang, William C; Devi-Rao, G V; Ghazal, Peter et al. (2002) General and specific alterations in programming of global viral gene expression during infection by VP16 activation-deficient mutants of herpes simplex virus type 1. J Virol 76:12758-74

Showing the most recent 10 out of 55 publications